Aaron Lyss Discusses Practice Transformation Under the OCM

May 30, 2020

The Oncology Care Model (OCM) has helped practices develop their capacity to use data for continuous quality improvement, said Aaron Lyss, MBA, director of strategy and business development at Tennessee Oncology.

The Oncology Care Model (OCM) has helped practices develop their capacity to use data for continuous quality improvement, said Aaron Lyss, MBA, director of strategy and business development at Tennessee Oncology.

Transcript:

How has Oncology Care Model (OCM) participation affected practice transformation?

OCM has impacted practice transformation in I think 3 important ways. One is the MEOS payments, or care management payments, associated with the model have underwritten a lot of the investments that practices have wanted to make in improving care delivery. The second way in which OCM has influenced practice transformation is by helping practices develop the capacity to use data for continuous quality improvement, with regard to care delivery that will be important for future participation in alternative payment models. I would say the third reason why OCM has impacted practice transformation is by augmenting the capacity for practices to implement the operational activities that are going to be necessary in the future for alternative payment models. A couple examples of this would be tracking attribution to these models and understanding the stop-loss insurance market, which practices would not have had to do without participating in OCM. That will be critical for them to be capable of going forward.